271 related articles for article (PubMed ID: 17044454)
1. Abnormal kinetics of erythrocyte sodium lithium countertransport in patients with diabetic nephropathy in Thailand.
Vareesangthip K; Panthongdee W; Shayakul C; Nitiyanant W; Ong-Aj-Yooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S48-53. PubMed ID: 17044454
[TBL] [Abstract][Full Text] [Related]
2. Abnormal thiol group modulation of sodium-lithium countertransport and membrane fluidity is associated with a disturbed relationship between serum triacylglycerols and membrane function in type II diabetes.
Senior PA; Thomas TH; Marshall SM
Clin Sci (Lond); 2000 Jun; 98(6):673-80. PubMed ID: 10814604
[TBL] [Abstract][Full Text] [Related]
3. Na/Li countertransport abnormalities in type 1 diabetes with and without nephropathy are familial.
Mead PA; Wilkinson R; Thomas TH
Diabetes Care; 2001 Mar; 24(3):527-32. PubMed ID: 11289480
[TBL] [Abstract][Full Text] [Related]
4. Abnormal kinetics of erythrocyte sodium lithium countertransport in renal transplant recipients.
Vareesangthip K; Hanlakorn P; Suwannaton L; Pidetcha P; Ong-Aj-Yooth L
Transplant Proc; 2004 Jun; 36(5):1367-71. PubMed ID: 15251334
[TBL] [Abstract][Full Text] [Related]
5. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
[TBL] [Abstract][Full Text] [Related]
6. Nephropathy and changes in sodium-lithium countertransport kinetics in type 2 (non-insulin-dependent) diabetes mellitus.
Rutherford PA; Thomas TH; Taylor R; Wilkinson R
J Hum Hypertens; 1994 Jan; 8(1):29-35. PubMed ID: 8151603
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
[TBL] [Abstract][Full Text] [Related]
8. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
Poch E; González-Núñez D; Compte M; De la Sierra A
Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
[TBL] [Abstract][Full Text] [Related]
9. Thiol group modulation of sodium-lithium countertransport kinetics in diabetic nephropathy.
Jones SC; Thomas TH; Marshall SM
Diabetologia; 1997 Sep; 40(9):1079-84. PubMed ID: 9300245
[TBL] [Abstract][Full Text] [Related]
10. Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension.
Mead P; Wilkinson R; Thomas TH
Hypertension; 1999 Dec; 34(6):1275-80. PubMed ID: 10601130
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte membrane thiol proteins associated with changes in the kinetics of Na/Li countertransport: a possible molecular explanation of changes in disease.
Thomas TH; Rutherford PA; Vareesangthip K; Wilkinson R; West IC
Eur J Clin Invest; 1998 Apr; 28(4):259-65. PubMed ID: 9615900
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy.
Lopes de Faria JM; Silveira LA; Morgano M; Pavin EJ; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1482-5. PubMed ID: 10798666
[TBL] [Abstract][Full Text] [Related]
13. Sodium-lithium countertransport and the Gly460-->Trp alpha-adducin polymorphism in essential hypertension.
Mead PA; Harvey JN; Rutherford PA; Leitch H; Thomas TH
Clin Sci (Lond); 2005 Mar; 108(3):231-6. PubMed ID: 15554870
[TBL] [Abstract][Full Text] [Related]
14. Modification of erythrocyte Na+/Li+ countertransport kinetics by two types of thiol group.
Thomas TH; West IC; Wilkinson R
Biochim Biophys Acta; 1995 May; 1235(2):317-22. PubMed ID: 7756341
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
Siebers RW; Maling TJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
[TBL] [Abstract][Full Text] [Related]
16. Abnormal effect of thiol groups on erythrocyte Na/Li countertransport kinetics in adult polycystic kidney disease.
Vareesangthip K; Thomas TH; Wilkinson R
Nephrol Dial Transplant; 1995 Dec; 10(12):2219-23. PubMed ID: 8808214
[TBL] [Abstract][Full Text] [Related]
17. Sodium/hydrogen exchange activity in type 1 diabetes mellitus: the never-ending story.
Matteucci E; Giampietro O
Diabetes Nutr Metab; 2001 Aug; 14(4):225-33. PubMed ID: 11716294
[TBL] [Abstract][Full Text] [Related]
18. Elevated erythrocyte sodium-lithium counter-transport in hypertensive patients with non-insulin-dependent diabetes mellitus.
Senda T; Serizawa N; Negishi K; Katayama S
Diabetes Res Clin Pract; 1996 Mar; 31(1-3):37-44. PubMed ID: 8792100
[TBL] [Abstract][Full Text] [Related]
19. Sodium-lithium countertransport is increased in normoalbuminuric type 1 diabetes but is not related to other risk factors for microangiopathy.
Vervoort G; Elving LD; Wetzels JF; Lutterman JA; Smits P; de Pont JJ; Berden JH
Eur J Clin Invest; 2002 Feb; 32(2):93-9. PubMed ID: 11895455
[TBL] [Abstract][Full Text] [Related]
20. Relevance of erythrocyte Na+/Li+ countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review.
Van Norren K; Thien T; Berden JH; Elving LD; De Pont JJ
Eur J Clin Invest; 1998 May; 28(5):339-52. PubMed ID: 9650006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
